ID
19136
Description
Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS; ODM derived from: https://clinicaltrials.gov/show/NCT00168766
Link
https://clinicaltrials.gov/show/NCT00168766
Keywords
Versions (1)
- 12/7/16 12/7/16 -
Uploaded on
December 7, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Relapsing-remitting Multiple Sclerosis NCT00168766
Eligibility Relapsing-remitting Multiple Sclerosis NCT00168766
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Relapse Recent
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0277556
- UMLS CUI [1,2]
- C0332185
Description
Immunosuppressive Agents Multiple Sclerosis
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0021081
- UMLS CUI [1,2]
- C0026769
Description
Major Depressive Disorder
Data type
boolean
Alias
- UMLS CUI [1]
- C1269683
Description
severe reaction Adrenal Cortex Hormones
Data type
boolean
Alias
- UMLS CUI [1,1]
- C3242604
- UMLS CUI [1,2]
- C0001617
Description
Pregnancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
Description
Diabetes Mellitus | Substance Dependence
Data type
boolean
Alias
- UMLS CUI [1]
- C0011849
- UMLS CUI [2]
- C0038580
Description
Hypersensitivity Investigational New Drugs
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0013230
Similar models
Eligibility Relapsing-remitting Multiple Sclerosis NCT00168766
- StudyEvent: Eligibility
C0919936 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
C0332185 (UMLS CUI [1,2])
C0026769 (UMLS CUI [1,2])
C0001617 (UMLS CUI [1,2])
C0038580 (UMLS CUI [2])
C0013230 (UMLS CUI [1,2])